This announcement is a separate document:
樂普生物-B：自願性公告MRG003用於治療復發性╱轉移性鼻咽癌(R/M NPC)新藥上市申請獲中國國家藥品監督管理局受理並納入優先審評
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTACCEPTANCE OF THE NEW DRUG APPLICATION AND PRIORITYREVIEW GRANTED BY NMPA TOMRG003 FOR THE TREATMENT OF R/M NPC
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated